PMV Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects …

Biotechnology
US, Cranbury [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of PMVP's Analysis
CIK: 1699382 CUSIP: 69353Y103 ISIN: US69353Y1038 LEI: - UEI: -
Secondary Listings
PMVP has no secondary listings inside our databases.